.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Ricardo Requena Platek

Madrid / ES

Spanish National Centre for Biotechnology (CNB-CSIC)

Speaker

5th May 2023
10:15 a.m. – 10:30 a.m. 10 Min. 5 Min.
Abstract Talk
AT 02
Improvement of efficacy and safety of SARS-CoV-2 RNA-replicon vaccine candidates using immunomodulatory miRNAs and miRNA-restricted tissue-specific tropism
Immune response to virus infection, SARS -CoV2 and other coronaviruses

Further involvements

5th May 2023
10:15 a.m. – 10:30 a.m. 10 Min. 5 Min.
Abstract Talk
AT 02
Improvement of efficacy and safety of SARS-CoV-2 RNA-replicon vaccine candidates using immunomodulatory miRNAs and miRNA-restricted tissue-specific tropism
Immune response to virus infection, SARS -CoV2 and other coronaviruses
5th May 2023
Poster Presentation
PP 095
Relevance of SARS-CoV-2 accessory genes to virulence in a transgenic mouse model of infection
Immune response to virus infection, SARS -CoV2 and other coronaviruses